A Guide to the Current Web-Based Resources in Pharmacogenomics

  • Dylan M. Glubb
  • Steven W. Paugh
  • Ron H. N. van Schaik
  • Federico Innocenti
Part of the Methods in Molecular Biology book series (MIMB, volume 1015)

Abstract

Human genomics research has produced vast amounts of data that can be applied to or used to inform pharmacogenomic studies. The Internet is an extremely useful resource for pharmacogenomics as many Web sites provide access to data from genomic and clinical studies or host tools which can be used to interpret findings or generate hypotheses. Human genetic variation can now easily be explored or visualized through genome browsers and Web-based repositories which store the details of millions of human germ-line and somatic genetic variants. Gene expression data from many different tissue and cell types are available through Web-based repositories, and human genetic variants that associate with mRNA expression can be identified using Web data portals. Pharmacogenetic associations can be explored through publically available data repositories and the functionality of genetic variants predicted through Web-based bioinformatic tools. Furthermore, resources relating to currently used genetic tests are available online. Large clinical and population studies, many linked to medical records, can be queried for the availability of biospecimens or data. In the future, as the amount of genomic and associated clinical data increases, there is little doubt that Web-based resources will continue to evolve and overcome barriers hindering their efficient use, leading to systems-based approaches to pharmacogenomics.

Key words

Genome browser Genetic variation Genotypes Gene expression eQTLs Genetic association studies GWAS Biorepositories Bioinformatic tools 

References

  1. 1.
    Wagner MJ (2009) Pharmacogenetics and personal genomes. Per Med 6:643–652PubMedCrossRefGoogle Scholar
  2. 2.
    Zhang W, Dolan ME (2010) Impact of the 1000 genomes project on the next wave of pharmacogenomic discovery. Pharmacogenomics 11:249–256PubMedCrossRefGoogle Scholar
  3. 3.
    Consortium, G.P (2010) A map of human genome variation from population-scale sequencing. Nature 467:1061–1073CrossRefGoogle Scholar
  4. 4.
    Rieder MJ et al (2008) The environmental genome project: reference polymorphisms for drug metabolism genes and genome-wide association studies. Drug Metab Rev 40:241–261PubMedCrossRefGoogle Scholar
  5. 5.
    Consortium, T.W.T.C.C (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678CrossRefGoogle Scholar
  6. 6.
    Hudson TJ et al (2010) International network of cancer genome projects. Nature 464: 993–998PubMedCrossRefGoogle Scholar
  7. 7.
    Roy NC et al (2011) A comparison of analog and Next-Generation transcriptomic tools for mammalian studies. Brief Funct Genomics 10:135–150PubMedCrossRefGoogle Scholar
  8. 8.
    Xia K et al (2012) seeQTL: a searchable database for human eQTLs. Bioinformatics 28:451–452PubMedCrossRefGoogle Scholar
  9. 9.
    Myers RM et al (2011) A user’s guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 9:e1001046CrossRefGoogle Scholar
  10. 10.
    Nakamura Y (2007) The BioBank Japan project. Clin Adv Hematol Oncol 5:696–697PubMedGoogle Scholar
  11. 11.
    Ollier W, Sprosen T, Peakman T (2005) UK Biobank: from concept to reality. Pharmacogenomics 6:639–646PubMedCrossRefGoogle Scholar
  12. 12.
    Angrist M (2009) Eyes wide open: the personal genome project, citizen science and veracity in informed consent. Per Med 6: 691–699PubMedCrossRefGoogle Scholar
  13. 13.
    Kho AN et al (2011) Electronic medical records for genetic research: results of the eMERGE consortium. Sci Transl Med 3:79re1PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2013

Authors and Affiliations

  • Dylan M. Glubb
    • 1
  • Steven W. Paugh
    • 2
  • Ron H. N. van Schaik
    • 3
  • Federico Innocenti
    • 4
  1. 1.Queensland Institute of Medical ResearchBrisbaneAustralia
  2. 2.Hematological Malignancies Program and Pharmaceutical Sciences DepartmentSt. Jude Children’s Research HospitalMemphisUSA
  3. 3.Department of Clinical ChemistryErasmus University Medical CenterRotterdamThe Netherlands
  4. 4.Division of Pharmacotherapy and Experimental TherapeuticsLineberger Comprehensive Cancer Center, Institute for Pharmacogenomics and Individualized Therapy, Eshelman School of Pharmacy, University of North CarolinaChapel HillUSA

Personalised recommendations